OnkoGenetiks® Hereditary Cancer Panel

Definition

Multi-gene hereditary cancer panels provide cost-effective screening in situations where a single family phenotype may be explained by more than one gene; they can include 14 to 30 cancer susceptibility genes. NCCN offers management recommendations for genes such as CDH1, MSH2, MLH1, MSH6, PMS2, PTEN, STK11 and TP53.

Method

Next Generation Sequencing

Accepted sample types

Blood (EDTA)

Description

275 gene regions associated with familial cancers are analyzed.

Inheritance

This is a germline (hereditary) multi-gene analysis; it forms the basis for cascade testing in family members and risk-reducing follow-up decisions.

Related Tests